过去一年中添加的文章，按日期排序
Anti-Resistant Strategies: Icotinib Derivatives as Promising Non-Small Cell Lung Cancer Therapeutics
Z Zhao, Y Du, X Chen - Current cancer drug targets - pubmed.ncbi.nlm.nih.gov
5 天前 - … from EGFR inhibitors like gefitinib. However, drug resistance remains a significant
challenge in treatment… cancer cell lines, with a specific focus on NSCLC cells that exhibit drug …
challenge in treatment… cancer cell lines, with a specific focus on NSCLC cells that exhibit drug …
Discovery of mutation-independent EGFR degrading bispecific antibodies that suppress tumor growth in preclinical tumor models
109 天前 - … and drug-like manufacturing properties, but can also be … limited by treatment-related
acquired resistance mutations … EGFR in multiple tumor cell lines covering a range of …
acquired resistance mutations … EGFR in multiple tumor cell lines covering a range of …